1
|
Charoo NA, Abdallah DB, Parveen T, Abrahamsson B, Cristofoletti R, Groot DW, Langguth P, Parr A, Polli JE, Mehta M, Shah VP, Tajiri T, Dressman J. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Moxifloxacin Hydrochloride. J Pharm Sci 2020; 109:2654-2675. [DOI: 10.1016/j.xphs.2020.06.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2020] [Revised: 05/05/2020] [Accepted: 06/03/2020] [Indexed: 01/31/2023]
|
2
|
Altan F, Corum O, Corum DD, Atik O, Uney K. Pharmacokinetics and bioavailability of marbofloxacin in lambs following administration of intravenous, intramuscular and subcutaneous. Small Rumin Res 2018. [DOI: 10.1016/j.smallrumres.2017.12.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
|
3
|
In vitro assessment of the antimicrobial susceptibility of caprine isolates of Mycoplasma mycoides subsp. capri. Vet J 2016; 214:96-101. [DOI: 10.1016/j.tvjl.2016.05.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2015] [Revised: 05/13/2016] [Accepted: 05/14/2016] [Indexed: 11/17/2022]
|
4
|
Moxifloxacin hydrochloride. PROFILES OF DRUG SUBSTANCES, EXCIPIENTS, AND RELATED METHODOLOGY 2014; 39:299-431. [PMID: 24794910 DOI: 10.1016/b978-0-12-800173-8.00007-6] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
A comprehensive profile of moxifloxacin HCl with 198 references is reported. A full description including nomenclature, formulae, elemental analysis, and appearance is included. Methods of preparation for moxifloxacin HCl, its intermediates, and derivatives are fully described. In addition, the physical properties, analytical methods, stability, uses and applications, and pharmacology of moxifloxacin HCl are also discussed.
Collapse
|
5
|
Rodgers T, Jones HM, Rowland M. Tissue lipids and drug distribution: Dog versus rat. J Pharm Sci 2012; 101:4615-26. [DOI: 10.1002/jps.23285] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2011] [Revised: 06/04/2012] [Accepted: 07/12/2012] [Indexed: 11/05/2022]
|
6
|
A Physiologically Based Pharmacokinetic Model of the Minipig: Data Compilation and Model Implementation. Pharm Res 2012. [DOI: 10.1007/s11095-012-0911-5] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
7
|
Sousa J, Alves G, Fortuna A, Falcão A. Analytical methods for determination of new fluoroquinolones in biological matrices and pharmaceutical formulations by liquid chromatography: a review. Anal Bioanal Chem 2012; 403:93-129. [DOI: 10.1007/s00216-011-5706-8] [Citation(s) in RCA: 63] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2011] [Revised: 12/24/2011] [Accepted: 12/29/2011] [Indexed: 11/25/2022]
|
8
|
Patel HB, Mody SK, Patel HB, Patel VA, Patel UD. Disposition Kinetic of Moxifloxacin following Intravenous, Intramuscular, and Subcutaneous Administration in Goats. ISRN VETERINARY SCIENCE 2011; 2011:584342. [PMID: 23738101 PMCID: PMC3658699 DOI: 10.5402/2011/584342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/05/2011] [Accepted: 12/20/2011] [Indexed: 11/23/2022]
Abstract
The present study was carried out to investigate disposition kinetics of moxifloxacin following single-dose intravenous (i.v.), intramuscular (i.m.), and subcutaneous (s.c.) administration at a dose rate of 5 mg/kg of body weight (b.wt.) in goats. Plasma samples collected after treatments were analyzed for drug concentration using high-performance liquid chromatography (HPLC). After i.v. administration, distribution of the drug was rapid and wide as reflected by high steady-state volume of distribution. Drug elimination was relatively faster with a total body clearance of 0.59 ± 0.03 L/h/kg. Following i.m. injection, the drug has shown the rapid and near-to-complete absorption with bioavailability of 98.20 ± 3.96 per cent. The maximum plasma drug concentration (Cmax) of 1.21 ± 0.04 μg/mL was attained at 1 h (Tmax). The drug was widely distributed as reflected by high apparent volume of distribution. The elimination half-life (t 1/2β ) of the drug was 6.26 ± 0.08 h. Following s.c. administration, the drug was rapidly absorbed (Cmax: 1.16 ± 0.02 μg/mL; tmax: 1 h) and slowly eliminated from the body. The elimination half-life and total body clearance (ClB) were 5.61 ± 0.10 h and 0.60 ± 0.03 L/h/kg, respectively. The bioavailability of moxifloxacin following s.c. administration was 90.44 ± 3.96 per cent.
Collapse
Affiliation(s)
- Harshad B Patel
- Department of Pharmacology and Toxicology, College of Veterinary Science and Animal Husbandry, Junagadh Agricultural University, Junagadh 362 001, Gujarat State, India
| | | | | | | | | |
Collapse
|
9
|
Pathania R, Sharma S. Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves. Res Vet Sci 2010; 89:108-12. [DOI: 10.1016/j.rvsc.2010.01.015] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2008] [Revised: 01/15/2010] [Accepted: 01/28/2010] [Indexed: 10/19/2022]
|
10
|
Speltini A, Sturini M, Maraschi F, Profumo A. Fluoroquinolone antibiotics in environmental waters: sample preparation and determination. J Sep Sci 2010; 33:1115-31. [PMID: 20187033 DOI: 10.1002/jssc.200900753] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The aim of this review is to provide a general overview on the analytical methods proposed in the last decade for trace fluoroquinolone (FQ) determination in environmental waters. A large number of studies have been developed on this topic in reason of the importance of their monitoring in the studies of environmental mobility and potential degradation pathways. Every step of the analysis has been carefully considered, with a particular attention to sample preparation, in relationship with the problems involved in the analysis of real matrices. The different strategies to minimise interference from organic matter and to achieve optimal sensitivity, especially important in those samples with lower FQ concentrations, were also highlighted. Results and progress in this field have been described and critically commented. Moreover, a worldwide overview on the presence of FQs in the environmental waters has been reported.
Collapse
Affiliation(s)
- Andrea Speltini
- Department of General Chemistry, University of Pavia, Pavia, Italy
| | | | | | | |
Collapse
|
11
|
Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration. Res Vet Sci 2010; 88:507-11. [DOI: 10.1016/j.rvsc.2009.11.009] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2008] [Revised: 06/25/2009] [Accepted: 11/11/2009] [Indexed: 11/22/2022]
|
12
|
GOUDAH A, CHO HJ, SHIN HC, SHIM JH, REGMI NL, SHIMODA M, ABD EL-ATY AM. Pharmacokinetics and milk distribution characteristics of orbifloxacin following intravenous and intramuscular injection in lactating ewes. J Vet Pharmacol Ther 2009; 32:338-44. [DOI: 10.1111/j.1365-2885.2008.01046.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
13
|
Cárceles CM, Escudero E, Fernández-Varón E, Marín P. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep. Vet J 2009; 180:343-7. [DOI: 10.1016/j.tvjl.2007.11.025] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2007] [Revised: 11/28/2007] [Accepted: 11/30/2007] [Indexed: 11/26/2022]
|
14
|
Goudah A. Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens. Br Poult Sci 2009; 50:251-8. [DOI: 10.1080/00071660802710108] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
15
|
Ko JY, Chang CY, Yang YH, Chen SH. Rapid Determination of Ciprofloxacin in Cerebrospinal Fluid by Micellar Electrokinetic Chromatography with Direct Sample Injection and its Application in Tuberculosis Meningitis. J LIQ CHROMATOGR R T 2009. [DOI: 10.1080/10826070802634513] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- Ju-Yun Ko
- a Department of Family Medicine, Kaohsiung Medical University , Kaohsiung, Taiwan
| | - Cheng-Ying Chang
- b Faculty of Pharmacy, College of Pharmacy, Kaohsiung Medical University , Kaohsiung, Taiwan
| | - Yuan-Han Yang
- c Department of Neurology , Kaohsiung Medical University Hospital , Kaohsiung, Taiwan
| | - Su-Hwei Chen
- b Faculty of Pharmacy, College of Pharmacy, Kaohsiung Medical University , Kaohsiung, Taiwan
- d Department of Pharmacy , Kaohsiung Medical University Hospital, and Center of Excellence for Environmental Medicine , Kaohsiung, Taiwan
| |
Collapse
|
16
|
Goudah A. Disposition kinetics of moxifloxacin in lactating ewes. Vet J 2008; 178:282-7. [PMID: 17900948 DOI: 10.1016/j.tvjl.2007.08.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2007] [Revised: 05/17/2007] [Accepted: 08/02/2007] [Indexed: 11/27/2022]
Abstract
The present study was planned to investigate the plasma disposition kinetics and the pattern of moxifloxacin elimination in the milk of lactating ewes (n=6) following a single intravenous (IV) bolus or intramuscular (IM) injections at a dosage of 5 mg/kg in all animals. A crossover study was carried out in two phases separated by 21 days. Plasma and milk samples were collected serially for 72 h and moxifloxacin concentrations were assayed using high performance liquid chromatography with fluorescence detection. A two-compartment open model best described the decrease of moxifloxacin concentration in the plasma after IV injection. The disposition after IM administration moxifloxacin was best described by a one-compartment model. Following IV administration, the distribution half-life (t(1/2alpha)) was 0.22+/-0.02 h. The elimination half-life was 1.77+/-0.23 h. The volume of distribution at steady state (V(dss)) was 0.84+/-0.12L/kg, the total body clearance (Cl(tot)) was 0.34+/-0.04 L/h/kg and the area under the curve (AUC) was 14.74+/-2.16 microg h/mL. Following IM administration, the mean T(max), C(max), t(1/2el) and AUC values for plasma data were 1.45+/-0.02 h, 2.21+/-0.27 microg/mL, 2.68+/-0.19 h and 14.21+/-2.35 microg h/mL. The IM bioavailability was 96.35+/-17.23% and the in vitro protein binding of moxifloxacin ranged from 32-37%. Penetration of moxifloxacin from the blood into milk was rapid and extensive, and the moxifloxacin concentrations in milk exceeded those in plasma from 1h after administration. The kinetic values AUC(milk)/AUC(plasma) and C(maxmilk)/C(maxplasma) ratios indicated a wide penetration of moxifloxacin from the bloodstream to the mammary gland. The in vitro minimum inhibitory concentration (MIC) of moxifloxacin for Mannheimia haemolytica was found to be 0.035 microg/mL.
Collapse
Affiliation(s)
- A Goudah
- Pharmacology Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
| |
Collapse
|
17
|
Abo-El-Sooud K, Goudah A. Pharmacokinetics and intramuscular bioavailability of difloxacin in dromedary camels (Camelus dromedarius). Vet J 2008; 179:282-6. [PMID: 18603456 DOI: 10.1016/j.tvjl.2008.05.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2008] [Revised: 05/02/2008] [Accepted: 05/13/2008] [Indexed: 10/21/2022]
Abstract
Single-dose disposition kinetics of difloxacin (5mg/kg bodyweight) were determined in clinically normal male dromedary camels (n=6) following intravenous (IV) and intramuscular (IM) administration. Difloxacin concentrations were determined by high performance liquid chromatography with fluorescence detection. The concentration-time data were analysed by compartmental and non-compartmental kinetic methods. Following a single IV injection, the plasma difloxacin concentration-time curve was best described by a two-compartment open model, with a distribution half-life (t(1/2alpha)) of 0.22+/-0.02h and an elimination half-life (t(1/2beta)) of 2.97+/-0.31h. Steady-state volume of distribution (V(dss)) and total body clearance (Cl(tot)) were 1.02+/-0.21L/kg and 0.24+/-0.07L/kg/h, respectively. Following IM administration, the absorption half-life (t(1)(/)(2ab)) and the mean absorption time (MAT) were 0.44+/-0.03h and 1.53+/-0.22h, respectively. The peak plasma concentration (C(max)) of 2.84+/-0.34microg/mL was achieved at 1.42+/-0.21h. The elimination half-life (t(1/2el)) and the mean residence time (MRT) was 3.46+/-0.42h and 5.61+/-0.23h, respectively. The in vitro plasma protein binding of difloxacin ranged from 28-43% and the absolute bioavailability following IM administration was 93.51+/-11.63%. Difloxacin could be useful for the treatment of bacterial infections in camels that are sensitive to this drug.
Collapse
|
18
|
GOUDAH A, ABO-EL-SOOUD K. Pharmacokinetics and milk penetration of orbifloxacin after intravenous and intramuscular injections to dromedary lactating camels (Camelus dromedaries). J Vet Pharmacol Ther 2008; 31:276-80. [DOI: 10.1111/j.1365-2885.2008.00954.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
19
|
ABD EL-ATY AM, GOUDAH A, SHAH SS, SHIN HC, SHIMODA M, SHIM JH. Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration. J Vet Pharmacol Ther 2007; 30:586-91. [DOI: 10.1111/j.1365-2885.2007.00908.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|